Estrella Immunopharma, Inc. Segments Disclosure
Note 11 — Segment Information
The Company conducts its business as a single operating and reportable segment based on its organizational and management structure and the manner in which the (“CODM”) reviews financial information to allocate resources and access performance, consistent with the Company’s segment reporting policy described in Note 2. The accounting policies of the Company’s single operating segment are the same as those described in Note 2. The key measure of segment profitability used by the CODM to allocate resources and assess performance is net income (loss), as reported on the consolidated statements of operations. The following table presents the significant expense categories of the Company’s operating segment for the periods presented.
| For the year ended December 31, 2025 | For the six months ended December 31, 2024 | |||||||
| Operating expenses: | ||||||||
| Clinical trial related service fee, a related party (see Note 5) | $ | 10,125,000 | $ | 2,801,435 | ||||
| Consulting fee | 82,228 | 75,000 | ||||||
| Stock-based compensation | 618,974 | 432,256 | ||||||
| Salary expense | 524,891 | 266,571 | ||||||
| Professional fee | 1,149,786 | 631,395 | ||||||
| Insurance expense | 335,658 | 169,513 | ||||||
| Other general and administrative fee | 226,137 | 75,794 | ||||||
| Loss before income tax | 13,062,674 | 4,426,964 | ||||||
| Income tax expense | 838 | 63 | ||||||
| Net loss | $ | 13,063,512 | $ | 4,427,027 | ||||
About Segments Disclosures
Segment disclosures break a company into its reportable operating units, revealing revenue, profit, and asset allocation that consolidated financial statements obscure. Under ASC 280, segments must match how the chief operating decision maker views the business, providing a window into internal management structure and resource allocation priorities.
Key signals: compare segment margins to identify which units drive profitability and which destroy value. Watch for changes in the number of reportable segments — segment aggregation or disaggregation often coincides with strategic shifts or attempts to obscure declining performance. Intersegment elimination patterns reveal internal pricing practices. The reconciliation between segment totals and consolidated figures exposes corporate overhead allocation and unallocated items. Geographic revenue concentration highlights regulatory and currency exposure. Compare segment-level capital expenditure against segment revenue to assess where management is investing for future growth versus harvesting existing assets.